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Kidney development has often served as a model for epithelial–mesenchymal cell interaction where the branching
epithelium of the ureteric bud induces the metanephrogenic mesenchyme to form epithelial nephrons. In a screen for genes
differentially expressed during kidney development, we have identified a novel gene that is dynamically expressed in the
branching ureter and the developing nephrons. It was designated Emu1 since it shares an N-terminal cysteine-rich domain
with Emilin1/2 and Multimerin. This highly conserved EMI domain is also found in another novel protein (Emu2) of similar
protein structure: an N-terminal signal peptide followed by the EMI domain, an interrupted collagen stretch, and a
conserved C-terminal domain of unknown function. We identified two further secreted EMI domain proteins, prompting us
to compare their gene and protein structures, the EMI domain phylogeny, as well as the embryonic expression pattern of
known (Emilin1/2, Multimerin) and novel (Emu1/2, Emilin3, Multimerin2) Emu gene family members. Emu1 and Emu2 not
only show a similar structural organization, but furthermore a striking complementary expression in organs developing
through epithelial–mesenchymal interactions. In these tissues, Emu1 is restricted to epithelial and Emu2 to mesenchymal
cells. Preliminary biochemical analysis of Emu1/2 confirmed that they are secreted glycoproteins which are attached to the
extracellular matrix and capable of forming homo- and heteromers via disulfide bonding. The widespread, but individually
distinct expression patterns of all Emu gene family members suggest multiple functions during mouse embryogenesis. Their
multidomain protein structure may indicate that Emu proteins interact with several different extracellular matrix
components and serve to connect and integrate the function of multiple partner molecules. © 2002 Elsevier Science (USA)
Key Words: Emilin; Multimerin; kidney; Emu1; Emu2; EMI domain; EndoGlyx-1; epithelial–mesenchymal interactions;
extracellular matrix; glycosylation; disulfide bonds; cysteine-rich; collagen.INTRODUCTION
Epithelial–mesenchymal interactions are involved in the
development of many different tissues, from structures like
hair and teeth to complex organs like salivary gland and
kidney. The mesenchyme directs budding and invagination
or sprouting and branching of the adjacent epithelial sheets
or tubuli. On the other hand, signals from the epithelium
may induce mesenchymal cells to transform into an epithe-
lial phenotype. Kidney development has often served as a
model for these processes: the metanephrogenic mesen-
chyme stimulates the branching of the ureteric bud that
differentiates into the collecting ducts. The ureteric bud in
turn induces the mesenchyme to convert into epithelial
1 To whom correspondence should be addressed. Fax: 49-931-nephrons (Davies and Bard, 1998). These inductive interac-
tions and differentiation processes are guided by a variety of
factors, including signaling molecules and their receptors,
various extracellular matrix (ECM) glycoproteins, ECM
receptors (integrins, dystroglycan), and cell adhesion mol-
ecules (CAMs). Protein modules often found in these differ-
ent proteins include oligomerization domains like collagen
repeats or coiled-coil regions as well as elements mediating
protein interaction like immunoglobulin-like or cysteine-
rich domains. Oligomerization assembles multiple protein
binding motifs and thereby leads to multivalency and high
binding strength (Engel and Kammerer, 2000).
ECM glycoproteins exhibit specific spatiotemporal ex-
pression patterns during organogenesis, and it is thought
that not only signaling between cells but also the interac-
tion of cells with ECM components play a crucial role in
tissue morphogenesis. During metanephric development,88-7038. E-mail: gessler@biozentrum.uni-wuerzburg.de.
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tenascin, fibronectin, and nidogen (entactin) are restricted
to the mesenchyme, whereas the basement membrane
components collagen IV and laminin 1 are specific for the
epithelium (Wallner et al., 1998). Organ culture experi-
ments and mouse knockout studies demonstrated that the
ECM is required for branching morphogenesis in the kidney
(Bullock et al., 1998; Davies et al., 1995; Ekblom, 1981;
Kreidberg et al., 1996; Roskelley et al., 1995). The ECM not
only serves as substrate for cell migration, epithelial cell
attachment, and polarization, but also contributes to the
patterns of tissue growth and branching in this system.
Epithelial Madin Darby canine kidney cells, for example,
can only be induced to form tubules by treatment with HGF
when they are embedded in collagen. When cultured on top
of the matrix, they migrate away from each other (Monte-
sano et al., 1991). Likewise, branching of the salivary gland
bud requires the deposition of collagen into the forming
clefts (Nakanishi et al., 1988). Without collagen, no clefts
are formed, while inhibition of the endogenous collagenase
leads to supernumerous clefts. In a similar fashion, proteo-
glycans not only provide a scaffold for cell movement or
tissue remodeling, but are involved in signaling processes.
Ligands like TGF, BMP, FGF, or Wnt are associated with
the ECM and have been shown to modulate the activity of
proteoglycans or vice versa (Flechtenmacher et al., 1996;
Kovacs et al., 1994; Liu et al., 1996; Ruoslahti and Yamagu-
chi, 1991). Heparan sulfate proteoglycans (HSPGs), for ex-
ample, act as low-affinity coreceptors for several signaling
molecules and thereby facilitate their dimerization, the
interaction with their receptors, or alter their effective
concentration (Schlessinger et al., 1995). Upregulation of
HSPG expression has been shown to activate Wnt activity
without increasing Wnt expression levels (Perreault et al.,
2001). On the other hand, interference with proteoglycan
synthesis leads to loss of Wnt expression (Kispert et al.,
1996). Integrins—large heterodimeric transmembrane
receptors—have a more direct role in signaling between
mesenchyme and epithelium. Different sets of integrin
receptors are expressed on mesenchymal or epithelial cells;
they receive signals from neighboring cells through inter-
action with ligands like vitronectin, tenascin, osteopontin,
or nephronectin at the mesenchymal–epithelial interface
and transduce this information into the cell. Thus, cell–cell
and cell–ECM adhesion as well as signaling are interlinked,
and it is difficult to clearly distinguish between scaffold-
providing and signaling activities. Moreover, there is a
steadily growing number of novel genes and gene families
involved in these interactions.
Initiated by a differential display screen for genes regu-
FIG. 1. Alignment of the deduced amino acid sequences of human
and mouse Emu1 and Emu2. The EMI domain, collagen repeat 1,
collagen repeat 2, and the novel domain X are indicated. Domain
boundaries are marked with arrows. Conserved residues are high-
lighted by shaded boxes.
205Expression and Characterization of Emu Family Members
© 2002 Elsevier Science (USA). All rights reserved.
lated during early kidney development, we have isolated
two novel genes named Emu1 and Emu2. Their proteins
share a cysteine-rich domain (EMI domain) with the ECM
glycoproteins Emilin and Multimerin. Comparative expres-
sion analysis has been performed for the entire EMI domain
family of genes. Further biochemical studies showed that
Emu1 and Emu2 encode glycosylated proteins that are
secreted into the extracellular space, where they form
homo- or heteromers to exert their function.
MATERIALS AND METHODS
Assembly of Emu Gene Sequences
Emu gene and amino acid sequence analyses were performed by
using the following software packages and Web-accessible pro-
grams: NCBI Blast, NIX, GCG, ClustalX, Treeview, and SMART.
DNA sequence assemblies were confirmed by sequencing the
respective I.M.A.G.E. cDNA clones or subcloned PCR fragments,
which were amplified with primers flanking questionable se-
quences. Human and mouse Emu1 and Emu2 sequences were
submitted to the EMBL database (Accession Nos. AJ416090–
AJ416093).
Cloning of Emu Sequences for Expression Studies
Forward and reverse oligonucleotides coding for Myc- or
HA-epitopes bearing XhoI adapter sites were annealed and
cloned into the XhoI site of the vector pCS2 (http://sitemaker.
med.umich.edu/dlturner.vectors) to get the tagging vectors
pCSmyc and pCSHA. The open reading frames of Emu1 and
Emu2 as well as the first 202 amino acids of Emu1 containing
the signal peptide and the EMI domain were amplified from
cDNA of stage E12.5 mouse embryos by using the Pfx polymer-
FIG. 2. Exon–intron and protein domain organization of human Emu family members. White boxes with numbers depict the numbers and
relative sizes of exons. Asterisks above Emu1 exons 4 and 10 indicate that corresponding exons are missing in Emu2. Colored boxes below
exons highlight protein domains: signal peptide (SP) in green, EMI domain in red, collagen repeats in black (col), coiled-coil regions (CC)
in yellow, domain X in gray, Clq domain in blue, and EGF repeat in orange. Scale bar, 100 amino acids (aa).
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ase (Invitrogen) and primers with BglII or EcoRI adapter se-
quences. PCR products were cloned in frame into pCSmyc or
p C S H A t o y i e l d p C S E m u 1 m y c , p C S E m u 2 H A , a n d
pCSEMI1myc. All inserts were sequenced to exclude PCR mu-
tations. Oligonucleotides used for cloning are as follows: Myc
epitope: myc-for-Xho, TCGAGGAACAGAAGCTGATTA-
GCGAAGAAGATCTGC; myc-rev-Xho, TCGAGCAGATCTT-
CTTCGCTAATCAGCTTCTGTTCC. HA epitope: HA-for-Xho,
TCGAGTACCCATACGACGTGCCAGACTACGCTC; HA-rev-Xho,
TCGAGAGCGTAGTCTGGCACGTCGTATGGGTAC. Emu1:
m-cgene-Bgl-ATG, GCGAGATCTGCGGTGGGGACGACAGCAT;
cfullAP2-Eco, CGCGAATTCCGTCTCCTGGGGGTGATGAT.
Emu2: Emu2Bg1ATG, GCGAGATCTGGAGAGCGGTGCAAAA-
TG; Emu2Eco, CGCGAATTCCTGTCGCCAGCCTGGTCT. EMI
domain of Emu1: m-cgene-Bgl-ATG (see above); cemil-Sal, CGCGTC-
GACTAAGGAAGCCCCCAAGAATCAA.
Cell Culture, Transfection, and Western Blot
Analysis
HEK293T cells were cultivated in DMEM medium supple-
mented with 10% fetal calf serum, 2 mM GlutamaxI, 100 U/ml
penicillin, and 100 g/ml streptomycin. Cells were plated on
100-mm plates and transfected with the expression constructs by
using the calcium phosphate method. After transfection, cells were
cultivated in serum-free medium (SFM II, Invitrogen) for 36–48 h.
The proteins from supernatants were precipitated with chloroform/
methanol. Glycosylation was analyzed by EndoHf digestion of
proteins from transfected cells or supernatants according to the
manufacturer’s protocol (NEB). For oligomerization studies, cell
lysates were prepared in protein sample buffer (50 mM Tris–HCl,
pH 6.8, 10% glycerin, 2% SDS, 1.5 mM bromphenolblue) with or
without 100 mM DTT (reducing/nonreducing). Protein samples
FIG. 3. (A) Amino acid sequence alignment of human and mouse EMI domains. Conserved cysteine residues are indicated below. Except
for Multimerin, all Emu family members contain seven cysteine residues in the EMI domain. The third cysteine is shifted in Multimerin2.
(B) Phylogenetic analysis of Emu proteins. The unrooted tree is based on the EMI domain alignment, and was generated by the Clustal X
neighbor joining algorithm. The Treeview program (http://taxonomy.zoology.gla.ac.uk/rod/rod.html) was used to draw the tree.
207Expression and Characterization of Emu Family Members
© 2002 Elsevier Science (USA). All rights reserved.
were separated by SDS–PAGE in 6 or 10% gels and transferred to
nitrocellulose membranes (Schleicher & Schuell). Monoclonal an-
tibodies against c-Myc (9E10) or HA (12CA5) (Sigma) were used as
primary antibodies, and goat anti-mouse antibody conjugated with
horseradish peroxidase was used as secondary antibody. Blots were
developed by using enhanced chemiluminescence (ECL; Amer-
sham Pharmacia).
For the production of stably transfected cell lines, HEK293 and
3T3 cells were cotransfected with PJ6puro (Morgenstern and
Land, 1990) and pCSEmu1myc or pCSEmu2HA in a 1:5 ratio. After
puromycine selection, single colonies were picked and expanded.
In vitro transcription and translation of pCSEmu1myc (full-
length Emu1) and pCSEMI1myc (EMI domain of Emu1) were
performed by using a coupled rabbit reticulocyte lysate system
(Promega). Products were visualized by Western blot analysis with
antibodies against the c-Myc epitope.
Indirect Immunofluorescence
For immunohistochemical studies, stably transfected cells were
grown on cover slips and fixed in 4% paraformaldehyde/PBS. To
stain for intracellular localization of Emu1/2 proteins, cells were
permeabilized with 0.2% Triton X-100/PBS for 10 min. Emu1myc
fusion protein expression was detected with 9E10 as primary and
Cy2-conjugated goat anti-mouse (Dianova) secondary antibody.
Emu2HA was stained with HA-probe (Y-11 rabbit sc-805; Santa
Cruz Biotechnology) as primary and Cy2-conjugated goat anti-
rabbit (Dianova) as secondary antibodies.
In Situ Hybridization
Mouse embryos of different stages were derived from timed
matings of CD1 outbred mice (Charles River Laboratories). In situ
hybridization of whole-mount embryos and of tissue sections using
digoxigenin-labeled antisense riboprobes was performed as de-
scribed (Leimeister et al., 1998). After color development, some
tissue sections were counterstained with nuclear fast red (Sigma).
Riboprobes were generated from the following constructs: Emu1,
coding sequence amplified from cDNA of stage E12.5 mouse
embryos cloned into pBluescript KS (primer sequences: m-cgene-
Bgl-ATG, GCGAGATCTGCGGTGGGGACGACAGCAT; m-
cgene-Stop-EcoRI, CGCGAATTCGCCTGCAGCCTCTCAGCTC-
CTC); Emu2, IMAGE clone (GenBank Accession No. AA028535);
Emilin3, IMAGE clone (GenBank Accession No. AW701511); Mul-
timerin2, cDNA insert of IMAGE clone (GenBank Accession No.
AI006581) subcloned into pBluescript KS; Emilin1, IMAGE clone
(GenBank Accession No. W59438); Emilin2, partial cDNA ampli-
fied from cDNA of stage E12.5 mouse embryos cloned into pCS2
(primer sequences: Emil4-5Bam, GCGGGATCCGGAATGTGC-
CACGCGATCT; Emil4-3Eco, GCGGAATTCGGATGGACAGG-
GCATCTGGT); Multimerin, partial cDNA amplified from cDNA
of stage E12.5 mouse embryos cloned into pDK101 (primer se-
quences: m-Multim2-5Bam, GCGGGATCCGTCTCTCGATT C-
CCCATGAA; m-Multim2-3code, CGGAGTAGCCGGGGCAR-
CANCKCCA). Primers for cDNA amplification of Emu1 coding
sequence, Emilin2, and Multimerin EMI domains were designed
according to mouse IMAGE clone or HTG sequences.
RESULTS
Identification of a Family of Secreted Proteins
Sharing an N-Terminal Cysteine-Rich Domain
In a screen for genes regulated during metanephrogenic
development, we have previously identified a genetag
(C0–5, GenBank EST W80149), which is dynamically ex-
pressed in the branching ureter and the developing
nephrons (Leimeister et al., 1999). Based on predictions
from human and mouse genomic and EST sequences (e.g.,
AL031186, Y07848, AC005528), we designed flanking prim-
ers to amplify the entire coding region of this gene. Se-
quence analysis of the cloned RT-PCR product from mouse
E12.5 RNA confirmed that it corresponds to the genetag
from the ddPCR screen. The presence of an upstream CpG
island extending into exon 1 and the good agreement of the
predicted transcript size with estimates from Northern
blots suggest that we have identified the complete exon–
intron structure. There is a high similarity (82% of nucle-
otides) between human and mouse exon sequences. The
deduced protein sequence contains an N-terminal signal
peptide followed by a cysteine-rich domain, an interrupted
collagen stretch, and a C-terminal domain without any
homology to known protein sequences (Fig. 1). Since a
similar, characteristic cysteine-rich domain, the EMI do-
main (Doliana et al., 2000), was also found in Emilin1,
Emilin2, and Multimerin, this novel protein was designated
Emu1. Further database searches yielded three additional
novel Emilin/Multimerin-related genes present in human
and mouse, designated Emu2, Emilin3, and Multimerin2.
Emu2 has an exon–intron and protein domain organization
very similar to Emu1 (Figs. 1 and 2). Moreover, phylogenetic
analysis of their EMI domains suggests that Emu1 and
Emu2 genes arose from a single ancestral gene through a
recent duplication event (Fig. 3B). The other two novel
proteins Emilin3 and Multimerin2 were likewise named
according to their grouping by protein domain structure,
exon–intron organization, and phylogeny (see below). Mul-
timerin2 was independently identified in a pursuit to find
new antigenic markers of human vascular endothelium and
designated there as EndoGlyx-1 (Christian et al., 2001). For
all human genes, the entire coding region was either avail-
able or could be reconstructed from genomic and EST
sequences (Fig. 2, Table 1). All exon–exon junctions were
verified by correctly spliced ESTs or sequencing of RT-PCR
products. For each of the corresponding mouse sequences,
the EMI domain could be also identified, but there are only
genomic shotgun sequences and no proven contiguous
cDNA sequence information available for the carboxy-
terminal regions of Emilin2, Multimerin, and Multimerin2
(EndoGlyx-1).
An alignment of all EMI domains from human and mouse
is shown in Fig. 3A. Each EMI domain, except in Multi-
merin, contains seven conserved cysteine residues, opening
the possibility for dimerization. Phylogenetic analysis of
these sequences confirmed the grouping of human and
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mouse sequences as evident by pairwise clustering (Fig. 3B).
For each human/mouse protein pair, the amino acid simi-
larity was in the 80–90% range. The excellent spatial
conservation of cysteines and additional highly conserved
amino acid residues together with an overall similarity of
50–70% between all members suggest that EMI domains
assume quite similar three-dimensional structures in these
proteins.
The Emu Gene Family Comprises Structurally
Different Members of Genes and Proteins
Emu domain proteins are expected to be secreted since
they start with a signal peptide, which is followed by the
adjacent EMI domain. Aside from these common features,
the proteins are divergent and can be subdivided into 2
classes (Fig. 2). Emu1 and Emu2 proceed with two collagen
stretches and a novel C-terminal domain. Interestingly, the
latter is highly conserved between the two genes and
between human and mouse, including a stretch of 17 amino
acids identical in all 4 proteins. Alternative splicing at the
3 splice site of intron 2 can lead to loss of 6 nucleotides
(amino acids SY) in human and mouse Emu1/2. Two
presumably orthologous genes with the same protein do-
main organization can even be found in Fugu rubripes
genome sequences and in other vertebrate genomes (data
not shown).
All other EMI domain proteins are significantly larger
than Emu1/2 and contain coiled-coil domains. The collagen
triple helix and the -helical coiled-coil represent the two
basic supercoiled multistranded protein motifs capable of
forming rod-like structures that may separate the presumed
globular domains of the N and C termini of all EMI-domain
proteins. With the exception of Emilin3, proteins of the
second class have a C1q domain at the C terminus that is
also implicated in protein oligomerization but may form
bouquet-like arrangements of trimers or higher oligomers
(Brodsky and Shah, 1995; Reid, 1989).
A similar subclassification of Emu proteins is also evi-
dent from the genomic organization of the respective genes:
Emu1 and Emu2 genes are composed of 15 and 13 small
exons spread over a large distance (Table 1, Fig. 2). All other
genes have a central or terminal very large exon encoding
the coiled-coil regions that span 600 or more amino acids.
In Emilin1, Emilin2, and Emilin3, the EMI domain is
encoded in exon 2 and only the first half of exon 3. While
Emilin1 and Emilin2 possess a collagen repeat followed by
a C1q domain in exons 5–8, this feature is absent from
Emilin3. In Emilin3, the first coiled-coil region may further
be shortened through the use of an alternative splice site in
exon 4 (Table 1).
The more distant members Multimerin and Multimerin2
again share the feature of an EMI domain spread over two
complete exons, but they contain the C1q domain in a
single exon. These data suggest that the pairs Emu1/2,
Emilin1/Emilin2, and Multimerin/Multimerin2 are likely
derived from a common ancestor each, with Emilin3 exhib-
iting strongest similarity to the Emilin1/Emilin2 pair.
Expression of the Novel and Known Emu Genes
during Mouse Embryogenesis
To elucidate a potential role of Emu proteins during
embryogenesis, we analyzed the expression of the murine
genes in E9.5–E17.5 embryos. Early stages of expression
were explored by whole-mount in situ hybridization, but
E14.5 and subsequent stages were analyzed on tissue sec-
tions.
TABLE 1
Sequence Characteristics of Emu Genes and Proteins
Human
chromosome Exons
Human
protein
(aa)
Mouse
protein
(aa)
Human
gene
size (kb)
Human
cDNA
Human
genomic Mouse cDNA
Mouse
genomic
Emu1 22q21.1 15 441/439 444/442 54 AJ416090 AL031186/
Y07848
AJ416093 AC005528*
Emu2 7q22.1 13 441/439 440/438 196 AJ416091 AC004953/
AC006329/
AC004965
AJ416092 AC083889*/
AC083857*
Emilin1 2p23.2 8 1016 1017 8 NM_007046 AC013403 BC005481 shotgun trace
sequences
Emilin2 18p11.32 8 1053 incompl. 67 NM_032048 AC015958* AA145049# shotgun trace
sequences
Emilin3 20q12 4 713/766 711/758 7 M802331# AL031667 BC002161# AL590389/
AL590430
Multimerin 4q22.1 8 1229 incompl. 60 NM_007351 AC093759* AK014984#/
codehop-PCR
shotgun trace
sequences
Multimerin2 10q23.2 7 949 incompl. 22 NM_024756 AC025268* BB618429 (5)/
AA624706 (3)
shotgun trace
sequences
*, draft sequences.
#, partial sequence.
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At E9.5, Emu1 is expressed in the dorsal neural tube, the
nephric duct, the otic vesicle, and the branchial cleft
epithelium (Fig. 4A). Emu2 is expressed in the somites, the
mesenchyme of the branchial arches, and the head (Fig. 4B).
At this early stage, Emilin3 expression is only visible in the
caudal part of the embryo, and vibratome sectioning local-
ized the staining in the gut (Fig. 4C; and data not shown).
With the onset of skeletal formation, Emilin3 transcripts
are additionally found at sites of cartilage and bone forma-
tion in the trunk and skull, i.e., surrounding mesenchymal
condensations in fore- and hindlimbs as well as the jaw
(E11.5, Fig. 4D). Multimerin2 is specifically expressed in
small and large blood vessels during embryogenesis (Fig.
4E). Emilin1 is expressed in mesenchymal cells throughout
the body, but especially in the trunk and the branchial
arches (Fig. 4F). Emilin2 expression is more restricted with
the main expression sites at the neural folds, the limb buds,
and the heart (Fig. 4G). Even after prolonged staining,
Multimerin transcripts are only observed in cells of un-
known origin forming two lines on both sides of the embryo
(Fig. 4H).
In E14.5 embryos, like in earlier ones, Emu1 is expressed
in the dorsal spinal cord and the brain, where it is restricted
to the proliferating ependymal and cortical cell layers (Fig.
5A). Additionally, Emu1 expression is observed in smooth
muscles of the digestive tract (Fig. 6G) as well as in the
epithelia of the salivary gland, the inner ear, and the
developing nephrons of kidney. In these latter organs, Emu2
is expressed in the adjacent mesenchyme — thus showing a
complementary expression pattern to Emu1 (Fig. 5B). Emu2
mRNA is further detected in the spinal nerves and ganglia,
in the head mesenchyme, and in skeletal muscles. Emilin3
is expressed in the nervous plexus of the digestive tract and
the main branches of the bronchi (Fig. 5C). Transcripts are
also found in the segmental interzone and surrounding
many sites of ossification, especially in the skull. As in
early embryos, Multimerin2 mRNA is observed in the
vascular endothelium and additionally in the spinal cord
and the brain (Fig. 5D). Emilin1 transcripts are seen
throughout the mesenchyme, in the diaphragm, in cartilage
(Fig. 5E), and in the outflow tract of the heart (Fig. 5I).
Emilin2 is expressed in interstitial cells throughout the
embryo and in the trabecular layer of the embryonic heart
(Fig. 5F). A speckled expression of Multimerin is observed
throughout the embryo which is very prominent in the lung
and often associated with blood vessels (Fig. 5G). In the
embryonic liver, Multimerin transcripts are restricted to a
few large cells with multilobulated nuclei, which are most
likely megakaryocytes (Fig. 5H).
At E17.5, Emu genes are expressed in the same tissues as
shown for E14.5 embryos (data not shown).
Comparison of Emu1 and Emu2 Gene Expression
Interestingly, Emu1 and Emu2 not only share a similar
gene and protein organization but are complementary ex-
pressed in several tissues developing through epithelial–
mesenchymal interactions. In early embryos, Emu1 is ex-
pressed in the epithelium of the branchial arches, whereas
Emu2 is localized to the adjacent mesenchyme (Figs. 4A
and 4B). At E14.5, Emu1 is restricted to the epithelium, but
Emu2 to the surrounding mesenchyme in the developing
kidney, the salivary gland, and the inner ear (Figs. 5A and
5B). This separation is also observed in these organs at later
stages (Figs. 6A–6F). However, in the advanced developing
kidney (at E15.5 and later), transcripts of both genes are
complementary only at the kidney periphery with Emu1 in
the epithelium of the developing nephrons and Emu2 in the
surrounding mesenchyme, but their expression overlaps in
the collecting duct epithelium (Figs. 6A and 6B). In some
tissues with comparable epithelial–mesenchymal interac-
tions, transcripts of both genes are absent (e.g., the lung) or
only Emu2 is expressed (e.g., the tooth). Moreover, in a
variety of other tissues, either Emu1 or Emu2 is expressed:
Emu1 in the spinal cord and in the smooth muscle cells of
the digestive tract (Fig. 6G) and Emu2 in the spinal ganglia
and the skeletal musculature (Fig. 6H). Thus, Emu1 and
Emu2 expression is complementary in some tissues, but
overlapping or exclusive in others.
FIG. 5. Embryonic expression of Emu genes in sagittal sections of E14.5-old mouse embryos. Nuclei are counterstained with nuclear fast
red, and specific gene expression is colored in blue. Gene names are indicated. (A) Emu1 is expressed in the future neopallial cortex (lv,
lateral ventricle), the dorsal spinal cord (sc), the epithelia of the salivary gland (sg), the kidney (k), and the inner ear (ie). (B) In these latter
organs, Emu2 is observed in the surrounding mesenchyme. Emu2 transcripts are further seen in the spinal nerves (sn) and ganglia, the
mesenchyme of the skull, the diaphragm (dp), and the skeletal muscles (sm). (C) Emilin3 is strongly expressed in the enteric nerves of the
digestive tract (dt) and the bladder (bl). Emilin3 transcripts are also observed surrounding the main branches of the alveoli (lu, lung) and
surrounding sites of bone formation in skull and trunk (si, segmental interzone). (D) Multimerin2 expression is restricted to endothelia of
blood vessels, the endocardium of the heart (h), and the spinal cord. (E) Emilin1 is expressed in mesenchymal cells throughout the body,
in the diaphragm (dp), in skeletal muscles, and in bones of the skull and trunk (v, vertebrae). Emilin1 is not observed in the heart ventricle
but in the outflow tract (see I). (F) Emilin2 transcripts are seen in the trabecular zone of the heart ventricle and in many mesenchymal cells
overlapping with Emilin1. (G) Multimerin is expressed in a speckled pattern throughout the body. Transcripts are found in endothelial cells
and megakaryocytes. (H) Magnification of Multimerin expression in megakaryocytes (mk) of the liver. (I) Emilin1 expression in the outflow
tract of the heart (at, aortic trunk; av, aortic valve).
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Emu1 and Emu2 Are Secreted N-Glycosylated
Proteins
To explore protein properties, we cloned the full-length
coding region of Emu1 and the EMI domain of Emu1 with
C-terminal Myc epitope-tags in eukaryotic expression vec-
tors. The coding region of Emu2 was similarly tagged with
the HA-epitope.
HEK293T cells were transiently transfected with these
expression constructs. Precipitated proteins from superna-
tants and cell lysates were analyzed by Western blotting
using anti-Myc and anti-HA antibodies. Emu1 and Emu2
proteins were detected in the cell lysates and, if at all, to a
lower extent in the supernatants. This suggests that they
are secreted but are attached to the extracellular matrix.
Therefore, the subsequent experiments were performed
with complete cell lysates. As seen in Fig. 7A, full-length
Emu1 and Emu2 recombinant proteins show a strong upper
band of approximately 60 kDa and a very faint lower band of
around 55 kDa, with the latter corresponding to the calcu-
lated molecular weight. Since there are two predicted
N-glycosylation sites (Asn-Xaa-Ser/Thr consensus) within
the EMI domains of Emu1 and Emu2, the slower migrating
protein products probably bear carbohydrate residues. In-
deed, when proteins from the cell lysates were digested
with endoglycosidase H (EndoH), which removes N-linked
carbohydrates, only the lower band is observed.
Analysis of cell lysates from cells transfected with the
EMI domain of Emu1 (EMI1) revealed an upper glycosylated
band of 30 kDa, but several lower protein bands, consistent
with more than one glycosylation site (Fig. 7B). In vitro
transcription and translation of full-length Emu1 or the
EMI1 domain expression constructs only generated protein
bands corresponding in size to the nonglycosylated protein
products (Fig. 7C). It remains to be seen whether there is
tissue- or cell-specific variation of glycosylation in vivo.
Oligomerization of Emu1/2 EMI Domains
The EMI domains of Emu1 and Emu2 include seven
cysteine residues, raising the possibility of dimerization or
oligomerization through disulfide bonds. To test whether
each of these proteins is capable of forming homomers via
disulfide bonding, we separated the tagged recombinant
proteins from transiently transfected HEK293T cells on
polyacrylamide gels under reducing or nonreducing condi-
tions. In addition to the monomeric 60-kDa band, slower
migrating bands of around 120 kDa, 180 kDa, and larger
were observed for Emu1 and Emu2 under nonreducing
conditions (Fig. 8A). This indicates that both proteins exist
as monomers, but they can form homodimers, -trimers, or
even larger complexes. The EMI1 domain of Emu1 alone
also form aggregates mainly of 90 kDa (trimer) but also of 60
kDa (dimer), 120 kDa (tetramer), 150 kDa (pentamer), or
higher aggregates (Fig. 8B, lane 2). When cells were cotrans-
fected with the full-length Emu1 and the EMI1 domain, the
same aggregates were observed. The contribution of Emu1
or EMI1 to the complexes cannot be distinguished because
they are both tagged with the Myc epitope and their sizes
are multiples of 30 kDa (Fig.8B, lane 3). We then cotrans-
fected full-length Emu2 and EMI1 to analyze a potential
heteromerization of Emu1 and Emu2. Since Emu2 was
tagged with the HA- and EMI1 with the Myc-epitope, we
could distinguish between the two proteins. Using anti-HA
for detection, we observed two high molecular weight
bands migrating between the full-length mono-, di-, and
trimeric Emu2 bands (Fig. 8C, lane5). These bands were not
observed when cells were transfected with Emu2 alone (Fig.
8C, lane 4) and are thus complexes of Emu2 and the EMI1
domain. This indicates that Emu1 and Emu2 are capable of
forming heteromeric complexes via their EMI domains.
Extracellular Matrix Association of Emu Proteins
When HEK293T cells were transiently transfected with
Emu1/2 expression constructs, we could not detect recom-
binant proteins in the supernatant, suggesting that they are
attached to the cells or the ECM. For a more thorough
analysis of Emu1/2 protein localization and in order to
exclude aberrant protein processing due to the massive
overexpression in transient transfections, we established
stably transfected cell lines. Cells were stained by immu-
nofluorescence with or without permeabilization. In per-
meabilized HEK293 and 3T3 cells stably expressing
Emu1myc or Emu2HA, proteins were localized in the ER
and the Golgi apparatus as well as on the cover slip, i.e., the
ECM secreted by the cells (Fig. 9). Without permeabiliza-
tion, only the strong extracellular fluorescence on the cover
slips was observed like a trace of the migrating cells. Thus,
Emu1/2 proteins are secreted and deposited in the ECM.
DISCUSSION
With Emu1 and Emu2, we have isolated two novel genes
that are specifically and often complementary expressed
during murine embryogenesis. The similarity of amino acid
sequences and strong parallels in gene and protein organi-
zation suggest a related function. Both genes encode se-
creted glycosylated proteins that are attached to the ECM
and are thus likely immobilized. The common EMI domain
defines a subfamily of seven genes and proteins with related
structure. In addition to Emu1/2, this domain is also found
at the N terminus of the secreted ECM molecules Emilin1,
Emilin2, and Multimerin, as well as in two novel proteins,
Emilin3 and Multimerin2. Related and evolutionary con-
served sequences have been detected in several vertebrate
species, including Fugu and zebrafish. The genomic organi-
zation as well as protein domain structure clearly suggest
an evolutionary history of gene pairs — with the exception
of the singleton Emilin3 that appears truncated at the C
terminus. The overall protein structure of most Emu pro-
teins is expected to be quite similar to the dumbbell shape
proposed for Emilin1, with globular N- and C-terminal
domains separated by a rod-like structure that is formed by
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FIG. 6. Comparison of Emu1 and Emu2 gene expression in sagittal sections of E15.5 (A–G) and E14.5 (H) mouse embryos. (A, B) In the
embryonic kidney at E15.5, Emu1 is expressed in the epithelia of the developing collecting duct and the nephron precursors, whereas Emu2
is expressed in the collecting ducts (cd) and the metanephrogenic blastem (mb) at the kidney periphery (ag, adrenal gland). (C, D) In the
salivary gland (sg), Emu1 transcripts are seen in the epithelial branches, while Emu2 transcripts are observed in surrounding mesenchymal
cells. (E) Emu1 is expressed in the cochlear epithelium (ce) of the inner ear. (F) Emu2 expression is observed in the surrounding mesenchyme
as well as in the cochlear ganglia (cg). (G) Emu1 is expressed in smooth muscles of the digestive tract. Here, expression in the inner muscles
(im) of the stomach (st) is shown. (H) Emu2 expression in skeletal muscles (sm) in E14.5-old embryos (v, vertebrae).
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coiled coils or collagen repeats (Colombatti et al., 2000;
Mongiat et al., 2000).
To provide a basis for future functional studies, we
investigated the embryonic expression of Emu1/2 and com-
pared it with the patterns of other Emu family members. In
a number of tissues developing through epithelial–
mesenchymal interaction, like kidney, salivary gland, inner
ear, and branchial arches, expression of Emu1 and Emu2 is
complementary. In the developing kidney, Emu1 is first
expressed in the branching ureter and Emu2 in the sur-
rounding mesenchyme that gets induced to form nephrons.
After transition of this mesenchyme into epithelial struc-
tures, Emu1 expression is then switched on. Epithelial-
specific expression of Emu1 and restriction of Emu2 tran-
scripts to subpopulations of mesenchymal cells are also
observed during the development of other organs. The
complementary expression of these two structurally related
proteins suggests that they may interact extracellularly at
boundaries to participate in the regulation of epithelial–
mesenchymal interaction and development. We detect such
heteromeric complexes in transfected cells, but it remains
to be seen whether Emu1 and Emu2 proteins — when made
by neighboring cells types — can still interact.
There is only limited overlap of Emu1/Emu2 mRNA
expression with other Emu family members. Multimerin2
transcripts are restricted to blood vessels and this endothe-
lial specific expression was also reported for the homolo-
gous human protein EndoGlyx-1 (Christian et al., 2001).
Multimerin is similarly found only in endothelial cells and
megakaryocytes. Emilin3 shows a very specific expression
in the nervous plexus of the digestive tract and the lung as
well as surrounding sites of cartilage or bone formation,
where neither Emu1 nor Emu2 expression overlaps or is
adjacent. Furthermore, no Emu protein aside from Emu1 is
epithelium-specific. Only Emu2 and Emilin1 are coex-
pressed in developing skeletal muscles. Furthermore, Emu2
seems to overlap with Emilin1/2 transcripts in the mesen-
chymal compartment of tissues, like kidney or salivary
gland. At higher resolution, however, it appears that Emi-
lin1 is strongly and Emilin2 weakly expressed in the inter-
stitial mesenchyme of the developing kidney, whereas
Emu2 is exclusively found in the peripheral mesenchyme
that transforms into nephrons and stroma. This suggests
that all EMI domain proteins may provide quite unique and
nonredundant functions to the respective tissue compart-
ments.
Little is known about the function of the cysteine-rich
EMI module. In yeast two-hybrid studies, it was shown that
the EMI domain of Emilin1 interacts with itself and with
the C1q domain of Emilin2, suggesting a role of this domain
in oligomerization of Emilin1 as well as head-to-tail asso-
ciation with Emilin2 (Doliana et al., 2000). We observed a
similar homophilic interaction of the EMI domain of Emu1
in yeast two-hybrid analysis (not shown). Nevertheless, the
physiological relevance of such interactions remains ques-
tionable given the fact that extracellular domains are
analyzed here, which are normally characterized by glyco-
sylation and multiple disulfide bonds. Probing such inter-
actions in a yeast nuclear compartment may hint at some
intrinsic affinity of the domains involved, but immunode-
tection of heteromers of tagged proteins as reported here for
Emu1 and Emu2 certainly represents a much more relevant
approach.
Cysteine-rich domains are frequently involved in
protein–protein interactions and they are found in numer-
ous extracellular and transmembrane proteins, from en-
zymes involved in blood coagulation to matrix proteins or
signaling molecules like BMPs, Wnts, and their receptors or
modulators. The EMI domain is characterized by the regu-
lar spacing of seven cysteines, a number found in TGF-
FIG. 7. N-glycosylation of Emu1 and Emu2 proteins. HEK293T cells were transiently transfected with the tagged full-length Emu1myc
and Emu2HA expression constructs (A) or the EMI domain of Emu1 (EMI1myc) (B). Protein extracts were incubated with or without
endoglycosidase H, separated on polyacrylamide gels under reducing conditions, and analyzed by Western blot. Molecular weight marker
(M) sizes are indicated on the left. (A) Untreated Emu1 and Emu2 full-length proteins migrate around 60 kDa (lanes 1 and 3). After removal
of carbohydrate residues, the sizes of Emu1 and Emu2 proteins are reduced to 55 kDa (lanes 2 and 4). (B) Without EndoH treatment, the fully
processed EMI1 domain has a molecular weight of around 30 kDa, but lower migrating partially processed bands are also observed (lane 1).
Digestion with EndoH removes the upper glycosylated bands (lane 2). (C) In vitro transcription/translation of EMI1myc (lane 1) and the
full-length Emu1myc (lane 2) protein.
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and several BMPs. These latter molecules form ho-
modimers, covalently linked by one of the seven cysteines,
while the other six cysteines form intramolecular disulfide-
bridges (cystin-knot). It is suggestive to propose a similar
mechanism of dimerization for the EMI domains that
would utilize the unpaired cysteine for intermolecular
bridging. Our biochemical analysis indeed shows that
mammalian Emu1 and Emu2 proteins are capable of form-
ing homo- as well as heteromers via disulfide bonds, al-
though homomers seem to be the favored aggregation state.
An important difference to BMP dimers lies in the fact
that we detect higher multimers that are held together by
disulfide bridges — even with the isolated EMI domain of
Emu1. Under nonreducing conditions, we found similar
amounts of Emu1 and Emu2 proteins as monomers, dimers,
and trimers. Since transient transfections result in a non-
physiological excess of protein, it remains to be seen
whether Emu1/2 proteins interact at different stoechiom-
etry in vivo. On the other hand, we cannot exclude that
even higher aggregates are formed that were not resolved in
the protein gels used. At least the EMI domain of Emu1 is
capable of forming tetra- or pentamers on its own, although
trimerization appears to be preferred. This suggests that the
EMI domain itself must have at least two surfaces for
homomeric interactions stabilized by disulfide bridges. In
this respect, it will also be interesting to analyze a potential
interaction of Emu1/2 with the EMI domains of the other
Emu proteins. Emilin1 and Multimerin proteins have been
shown to multimerize to form very large molecular com-
plexes of several million daltons that are highly disulfide-
linked with the smallest protomer being a trimer (Hayward
et al., 1991; Mongiat et al., 2000). Similarly, EndoGlyx-1
(Multimerin2) of HUVECs and EA.hy926 cells assembles to
form a disulfide-linked complex of three subunits. Stretches
of coiled-coil domains implicated in oligomerization to
three-stranded or five-stranded complexes as well as triple
helices of C1q that are known to further multimerize to
form a bouquet-like quaternary structure may contribute to
these aggregates (Brodsky and Shah, 1995; Reid, 1989).
Emu1/2 instead have triple-helix-forming collagen repeats,
making it likely that the central domains of Emu1 and
Emu2 assemble to form trimers. As in collagens XII or XIV,
there are two separate and comparatively short collagen
repeats in Emu1/2. One could envisage incorporation of
Emu1/2 into collagen fibers as a macromolecular intercon-
nector, similar to FACIT collagens. In this way, both the
EMI domain and the novel C-terminal domain X would be
available for further interactions and network formation.
The domain X of Emu1 and Emu2, which has not been
described previously, is almost identical in human and
mouse and even in Fugu, tetraodon, and zebrafish se-
quences. This points to a conserved function that may well
extend beyond that of an initiator for the assembly of the
flanking collagen triple helix. We expect that in situ local-
ization of Emu proteins using specific antisera, protein
interaction studies, and gene knockout will provide new
insight into the role of the Emu class of extracellular matrix
proteins in various developmental processes.
FIG. 8. Emu1 and Emu2 proteins are linked by disulfide bonds.
Transiently transfected HEK293T cell lysates were denatured in
reducing (DTT) or nonreducing (DTT) sample buffer and ana-
lyzed by Western blot. Molecular weight marker (M) sizes are
indicated. (A) Homomerization was analyzed in cells transfected
either with Emu1myc or Emu2HA and detected with anti-Myc and
anti-HA, respectively. Under nonreducing conditions, slower mi-
grating bands corresponding to the size of homodimers and ho-
motrimers of Emu1 or Emu2 are seen (lanes 2 and 4, respectively).
(B, C) To investigate heterodimerization of Emu1 and Emu2, cells
were transfected with Emu1myc (lane1), EMI1myc (lane 2),
Emu1myc plus EMI1myc (3), Emu2HA (lane 4), or Emu2HA plus
EMI1myc (lane 5). (B) Staining with anti-Myc as primary antibody
reveals all Myc-tagged Emu1 proteins or complexes. Lanes 1 and 2
show the monomers and oligomers of Emu1 or the EMI1 domain
alone. Note that the EMI1 domain forms mainly trimers (arrow in
B). (C) A parallel Western blot was analyzed with the HA antibody
staining Emu2. In lysates from cells transfected with full-length
Emu2 monomeric (60 kDa), dimeric (120 kDa) and trimeric (180
kDa), as well as the unprocessed monomeric bands (55 kDa) were
observed (lane 4). Two additional interbands (arrows in C) appear
when cells were cotransfected with full-length Emu2 and the EMI1
domain, demonstrating that heteromeric complexes between the
two proteins are formed (90 and 150 kDa) (lane 5).
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